American Society for Reproductive Medicine. (2021). Revised American Society for Reproductive Medicine classification of uterine anomalies. Fertility and Sterility, 115(3), 532-550.
[2]
Bendifallah, S., & Daraï, E. (2020). Uterine fibroids: Diagnosis and management. The Lancet, 395(10220), 521-532.
[3]
Di Spiezio Sardo, A., et al. (2019). hysteroscopic treatment of uterine septum: A review of the literature. Journal of Minimally Invasive Gynecology, 26(5), 847-856.
[4]
Hooker, A. B., et al. (2021). Prevalence, symptoms and management of uterine polyps: A multinational study. Journal of Minimally Invasive Gynecology, 28(3), 567-574.
[5]
Kumar, N., et al. (2020). Asherman's syndrome: Current perspectives on diagnosis and management. International Journal of Women's Health, 12, 893-901.
[6]
Ludwin, A., et al. (2019). ESHRE/ESGE consensus on the classification of female genital tract congenital anomalies. Human Reproduction, 34(8), 1552-1568.
[7]
Pritts, E. A., et al. (2020). Fibroids and infertility: An updated systematic review of the evidence. Fertility and Sterility, 113(4), 722-738.
[8]
WHO. (2021). Infertility definitions and terminology. World Health Organization Technical Report Series.
[9]
Zhang, Y., et al. (2022). Advances in the understanding of uterine factor infertility. Reproductive Biology and Endocrinology, 20(1), 45-58.
[10]
Zupi, E., et al. (2021). Uterine fibroid management: From clinical practice to guidelines. International Journal of Women's Health, 13, 451-464.